期刊
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
卷 17, 期 4, 页码 611-627出版社
ELSEVIER SCI LTD
DOI: 10.1016/S1521-6942(03)00030-5
关键词
pain; fibromyalgia; fatigue; sleep; antidepressants; noradrenaline; norepinephrine; serotonin; anti-epileptic; opiate; sedative; hypnotic; NMDA; growth hormone
类别
The fibromyalgia syndrome (FMS) is a common, chronic, widespread pain disorder that mainly affects middle-aged women. In addition to pain complaints, fatigue and disturbed sleep are symptoms frequently reported by these patients. Many FMS patients also meet diagnostic criteria for mood disorders (e.g. depression) as well as other so-called 'functional somatic syndromes', including irritable bowel syndrome, temporomandibular joint disorder, and subsets of chronic low-back pain. A wide variety of medications are used to manage the eclectic symptomatology of FMS patients, although relatively few have been rigorously tested. This chapter provides a contemporary update of the state of FMS pharmacotherapy, with an emphasis on compounds that have been tested in double-blind, randomized, controlled trials. Particular attention is paid to the efficacy of these therapies on the associated symptoms and co-morbid syndromes commonly seen in FMS patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据